What has hurt value funds during the pandemic?

Aussie-equities/growth-funds/

25 September 2020
| By Laura Dew |
image
image
expand image

Value funds have suffered a “torrid time” for the past decade but a range of factors during the pandemic have caused them to suffer even worse than usual.

According to Morningstar, value funds had been hindered in recent years by asset price inflation which had left only a small hunting ground for them to find value stocks. This worsened during the COVID-19 pandemic with value funds experiencing higher volatility and higher downside capture than their growth counterparts.

“While value’s underperformance over the first half of 2020 is disappointing, it is not unexplainable,” the data provider said. “Both the healthcare and technology stocks have long been favoured domains of growth managers, with many stocks priced out of reach of the typical value manager.

“Meanwhile, value has become increasingly concentrated in fewer areas over recent years – most notably in deep cyclicals such as the energy sector and leveraged businesses like financials. These two areas are highly sensitive to real economic activity and have been most exposed to the lockdowns aimed at supressing the spread of the virus.”

As well as this, it had been challenged by the unprecedented monetary stimulus initiated by central banks worldwide which was showing no signs of ending soon.

According to FE Analytics, within the Australian Core Strategies universe, there were 14 funds within the 228 funds in the Australian equity sector which identified themselves as being ‘value’ funds.

Since the start of the year to 31 August, only two of these funds had positive returns over the period. These were the Ganes Focused Value and the Prime Value Opportunities funds which had returned 2.14% and 1.8% respectively.

The Australian equity sector had lost, on average, 5.9% over the same period and eight of the value funds had performed worse than this. The worst-performing fund was the AXA Wholesale Australian Equity Value which lost 16.4% over the period.

However, Morningstar was reluctant to write-off the asset class as it felt cyclicals could yet see a “massive rally” which would boost value funds.

“As the economic downturn has been sharp and deep, the rebound could equally surprise. The sugar-hit of massive fiscal stimulus may gain more traction in the event of a breakthrough vaccine or therapeutic. In such an event, deep cyclicals could rally hard while any emergence of inflationary pressure as a consequence of all this money printing could see interest rates rise and apply the handbrake on growth’s re-rating.”

Read more about:

AUTHOR

Recommended for you

sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

MARKET INSIGHTS

So we are now underwriting criminal scams?...

1 month 3 weeks ago

Glad to see the back of you Steve. You made financial more expensive, not more affordable as you claim, and presided ...

2 months ago

Completely agree Peter. The definition of 'significant change is circumstances relevant to the scope of the advice' is s...

4 months ago

Entireti has unveiled the new name for the AMP financial advice businesses that it acquired last year....

4 weeks ago

A Sydney financial adviser has been permanently banned from providing any financial services, with the regulator deriding his “lack of integrity, trustworthiness and prof...

2 weeks 6 days ago

Minister for Financial Services, Stephen Jones, has provided further information about the second tranche of the Delivering Better Financial Outcomes (DBFO) reforms....

1 week 5 days ago

TOP PERFORMING FUNDS